Steven A. Shallcross
Board Member
Theriva Biologics, Inc. (TOVX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Steven A. Shallcross
Steven A. Shallcross is recorded as Board Member at Theriva Biologics, Inc. (TOVX). Theriva Biologics, Inc. reported in an 8-K filed August 4, 2026 that Steven A. Shallcross was appointed Director, effective August 3, 2026. Theriva Biologics, Inc. reported in an 8-K filed September 4, 2025 that Steven A. Shallcross was appointed Director, effective August 29, 2025. Theriva Biologics, Inc. reported in an 8-K filed November 1, 2024 that Steven A. Shallcross was appointed director, effective October 31, 2024. Equibles holds 5 filed executive changes naming Steven A. Shallcross; each is listed under recent activity with its source filing. The proxy statement of Theriva Biologics, Inc. reports total compensation of $876,313 for Steven A. Shallcross in fiscal 2024, including a base salary of $644,963. Disclosed compensation is on record for 6 fiscal years.
“The following four (4) individuals were elected as directors, to serve until the Company’s next annual meeting of stockholders and until their respective successors have been duly elected and qualified with the following votes:”
“The following four (4) individuals were elected as directors, to serve until the Company's next annual meeting of stockholders and until their respective successors have been duly elected and qualified with the following votes:”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2018-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Theriva Biologics, Inc.
Other people whose current roles at this company are on record from its filings.
- Frank Tufaro COO
- Jeffrey J. Kraws Board Member
- Jeffrey Wolf Board Member
- John Monahan Board Member
- John Monahan, Ph.D. Board Member
- Scott L. Tarriff Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Theriva Biologics, Inc. (TOVX) | Chief Executive Officer and Chief Financial Officer | $644,963 | $876,313 |
| 2023 | Theriva Biologics, Inc. (TOVX) | Chief Executive Officer and Chief Financial Officer | $614,250 | $1,271,913 |
| 2021 | Theriva Biologics, Inc. (TOVX) | Chief Executive Officer and Chief Financial Officer | $584,775 | $1,121,124 |
| 2020 | Theriva Biologics, Inc. (TOVX) | Chief Executive Officer and Chief Financial Officer | $565,000 | $1,062,519 |
| 2019 | Theriva Biologics, Inc. (TOVX) | Chief Executive Officer and Chief Financial Officer | $550,000 | $1,108,609 |
| 2018 | Theriva Biologics, Inc. (TOVX) | Chief Executive Officer and Chief Financial Officer | $489,421 | $963,411 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.